Founder and former CEO Nick Arab to transition to CTO and focus on advancing Pattern’s single-cell microbiology technology Austin, TX – January 9, 2025 – Pattern Bioscience, an innovator in rapid diagnostic technologies for bacterial infections, today announced...
Austin, TX – November 21, 2024 – Pattern Bioscience, an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections, today announced it has been awarded a cost-share contract worth up to $40.9 million by the Biomedical Advanced Research...
AUSTIN, Texas — July 31, 2023 — Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, today announced that it was named the winner of the Disruptive Technology Award from the Association for...
New funding will be used to accelerate development of first-of-its-kind infectious disease diagnostic platform that will deliver rapid antibiotic treatment guidance AUSTIN, Texas — April 27, 2023 — Pattern Bioscience, Inc., an innovator in rapid diagnosis and...
Renowned microbiologist will bring clinical expertise as the company advances its platform for rapid pathogen identification and antibiotic susceptibility testing AUSTIN, Texas — March 10, 2022 — Pattern Bioscience, Inc., developer of Digital Culture™ technology for...
